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Introduction to the review articles
We celebrate the 20th anniversary of
Immunohematology this year by publishing four
special issues that are primarily devoted to review
articles. The reviews in this, the first, issue focus on the
major RBC blood group systems. Each blood group
system is genetically discrete and consists of one or
more antigens. The antigens are surface markers on the
outside of the RBC membrane and are proteins and
carbohydrates attached to lipid or protein. Exposure to
RBCs carrying an antigen lacking on the RBCs of the
recipient can elicit an immune response in some
people. The ability to detect and identify blood group
antigens and antibodies by simple hemagglutination
techniques is the foundation of safe, supportive blood
transfusion practice and the appropriate management
of pregnancies at risk for HDN.
Currently there are 29 blood group systems,
containing 229 antigens, recognized by the
International Society of Blood Transfusion (ISBT).
Twenty years ago, at the launch of
Immunohematology, there were 16 systems with 144
antigens and quite a collection of antigens waiting to
be assigned to systems, pending the discovery of new
information about their relationship to the established
systems. During the last 10 to 15 years, major
advances, particularly at the molecular level, have
occurred in our understanding of blood group
antigens, the structures that carry them, and the red
cell membrane that houses them. The study of people
who have a null phenotype for a certain blood group
system and thus have RBCs that lack or have altered
membrane protein(s) has provided a key to the
function of that protein. The reviews in this issue, each
in a unique way, address the exciting findings of recent
years and consider the molecular events that generate
diversity in blood group antigens and phenotypes and
relate them back to possible applications at the clinical
level.
The discovery of the ABO groups at the beginning
of the 20th century made blood transfusion possible.
Therefore, it is fitting that ABO is the first system to be
reviewed and that Dr. Fumiichiro Yamamoto, who was
a member of the team that cloned the ABO genes, does
so. Dr. Yamamoto’s article begins with Landsteiner’s
work, then guides us through the elucidation of the
biochemical nature of the ABO antigens, the isolation
of the transferases involved in the syntheses of A and B
antigens, the cloning of the ABO genes, and the
molecular basis of the serologically defined
phenotypes. The ABO genes in other species; the
evolution of the ABO genes; and changes in antigen
expression during development, differentiation, and
carcinogenesis are also discussed. He concludes the
review by leaving us to muse over the question of “Why
does the ABO polymorphism exist?”
The Rh system, after ABO, is the most clinically
significant in transfusion medicine. The identification
of the Rh antigens led to the understanding and
prevention of HDN. Dr. Franz Wagner and Dr. Willy
Flegel review the Rh system in this issue of
Immunohematology. The authors, through their work
in recent years, have contributed to our understanding
of this, the most polymorphic and complex of the
blood group systems. The Rh antigens are considered
at the level of the gene, the protein, and the antigen.
Current knowledge of the molecular bases of Rh
antigen expression is used to shed light on the
serologic complexity of the Rh blood group system. In
particular, the molecular bases of D antigen expression,
of the partial D, weak D, Del, and D-negative
phenotypes, is extensively reviewed, as is the
phylogeny of RHD alleles. The available molecular
information for each of the 48 Rh antigens is also
presented in a tabulated format for easy reference. The
authors conclude their review by drawing our
attention to the many unresolved questions about the
Rh system and in particular the “astounding Rh
antigenic variability.”
Dr. Connie Westhoff and Dr. Marion Reid focus on
the Kell, Duffy, and Kidd blood group systems. The
antibodies to antigens in these three systems are the
most clinically significant, after those of ABO and Rh.
Because of the association between Kx and Kell, the Kx
system is included. The authors have distilled the
wealth of information about these systems into a few
pages of text and several informative tables and figures.
The history of each system is addressed (e.g., Kell was
the first system to be identified after the introduction
of the antiglobulin test), then the antigens, the
antibodies, and their involvement in HDN. The recent
advances at the gene and protein levels and the
molecular bases of the antigens and phenotypes are
L E T T E R  T O  T H E  R E A D E R S
summarized. The biological role of the Kell, Kidd, and
Duffy proteins and their significance in health and
disease are also discussed.
The authors of the fourth review, Karen and Peter
Byrne, faced a daunting challenge, that of describing
“Other Blood Group Systems.” They selected those
systems considered to be of clinical importance or to
have interesting features and made the scope of the
presented information “What you need to know for the
SBB exam.” The eight blood group systems featured in
this review are Diego, Yt, Xg, Scianna, Dombrock,
Colton, Landsteiner-Wiener, and Indian. The
information presented by the authors should prove
valuable to those immunohematologists studying for
the SBB exam
Finally, in addition to the four reviews, two original
articles are published in this information-rich
anniversary issue of Immunohematology.
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REMEMBER:  THE PASSWORD IS “2000” For www.redcross.org/pubs/immuno
Now, as a subscriber, you can enter the password, 2000, and access the back issues. That means
cover to cover!  You will receive every article in total, every letter to the editor, every review, every ad, every
notice, and every literature review!  All of the other services will continue to be available on the Web site,
including sending a letter to the editor, subscribing with a credit card on the secure order site, performing a
literature search, reviewing instructions for authors, and linking to other important sites. Log on now to see
this great service!
Manuscripts: The editorial staff of Immunohematology welcomes manuscripts pertaining to blood group
serology and education for consideration for publication.We are especially interested in case reports, papers
on platelet and white cell serology, scientific articles covering original investigations, and papers on the use of
computers in the blood bank. Deadlines for receipt of manuscripts for consideration for the March, June,
September, and December issues are the first weeks in November, February, May, and August, respectively.
Instructions for scientific articles and case reports can be obtained by phoning or faxing a request to Mary H.
McGinnniss, Managing Editor, Immunohematology, at (301) 299-7443, or see “Instructions for Authors” in
every issue of Immunohematology or on the Web. Include fax and phone numbers and e-mail address
with your manuscript.
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